Other reports have described a high level of H3K27me3 as an indicator of good prognosis; however, H3K27me3 is usually lost in ovarian cancer, contradictory to the oncogenic role of EZH2 as the H3K27me3 methyltransferase [12]. This evidence concerns the gene EZH2 and ovarian cancer.